Objective To assess the efficacy, tolerability, and safety of cannabinoids (phyto‐and syntheto‐
) in the management of rheumatic diseases. Methods Multiple databases, including Medline …

BACKGROUND: Recent neurophysiological evidence attests to the validity of fibromyalgia
(FM), a chronic pain condition that affects> 2% of the population. OBJECTIVES: To present …

Mary-Ann Fitzcharles has received consulting fees, speaker fees and honor aria from
Janssen, Eli Lilly, Pfizer, Purdue Pharma and Valeant Pharmaceuticals International. She …

BACKGROUND: As pain is the cardinal symptom of fibromyalgia, it is logical that treatments
directed toward pain relief will be commonly used. Analgesic drug therapy remains the …

Objectives Patient Global Rating of Change (GRC) scales are commonly used in routine
clinical care given their ease of use, availability and short completion time. This analysis …

Background Arthritis pain is reported as one of the most common reasons for persons using
medical herbal cannabis in North America.“Severe arthritis” is the condition justifying legal …

Objective. To summarize the development of evidence-based guidelines for the clinical care
of persons with fibromyalgia (FM), taking into account advances in understanding of the …

Objective. Although persons with lower socioeconomic status (SES) generally have poorer
health status for many medical conditions, the association of SES with symptom severity in …

2. Materials and methods The study was approved by Institutional Review Board Services
(IRB Services), Ontario Canada, an independent Ethics Review Board in accordance with …

Background Fibromyalgia (FM) is a pain condition with associated symptoms contributing to
distress. The Fibromyalgia Survey Diagnostic Criteria and Severity Scale (FSDC) is a patient …